JBM (Healthcare) Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG1090B1077
HKD
2.79
0.01 (0.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 2,187 Million ()

stock-summary
P/E

47.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.16

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

2.04

Revenue and Profits:
Net Sales:
176 Million
(Quarterly Results - Jun 2010)
Net Profit:
14 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.11%
0%
-2.11%
6 Months
-3.79%
0%
-3.79%
1 Year
56.74%
0%
56.74%
2 Years
190.63%
0%
190.63%
3 Years
267.11%
0%
267.11%
4 Years
179.0%
0%
179.0%
5 Years
16.25%
0%
16.25%

JBM (Healthcare) Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
14.46%
EBIT Growth (5y)
23.06%
EBIT to Interest (avg)
14.65
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.60
Tax Ratio
37.67%
Dividend Payout Ratio
70.60%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
47
Industry P/E
Price to Book Value
2.25
EV to EBIT
29.43
EV to EBITDA
27.04
EV to Capital Employed
2.30
EV to Sales
3.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.82%
ROE (Latest)
4.79%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'10 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2010 is 3.46% vs 5.97% in Jun 2009",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2010 is 58.89% vs 125.00% in Jun 2009",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'10",
        "Jun'09",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.20",
          "val2": "170.30",
          "chgp": "3.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.50",
          "val2": "15.50",
          "chgp": "58.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "1.60",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.30",
          "val2": "9.00",
          "chgp": "58.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2023 is 28.12% vs 2.24% in Mar 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2023 is 171.67% vs -23.86% in Mar 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "520.30",
          "val2": "406.10",
          "chgp": "28.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "111.40",
          "val2": "84.10",
          "chgp": "32.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.20",
          "val2": "6.40",
          "chgp": "28.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.10",
          "val2": "-2.50",
          "chgp": "304.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "63.30",
          "val2": "23.30",
          "chgp": "171.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "130.20%",
          "val2": "89.50%",
          "chgp": "4.07%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'10 - YoYstock-summary

Jun'10
Jun'09
Change(%)
Net Sales
176.20
170.30
3.46%
Operating Profit (PBDIT) excl Other Income
24.50
15.50
58.06%
Interest
1.40
1.60
-12.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.30
9.00
58.89%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2010 is 3.46% vs 5.97% in Jun 2009

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2010 is 58.89% vs 125.00% in Jun 2009

Annual Results Snapshot (Consolidated) - Mar'23stock-summary

Mar'23
Mar'22
Change(%)
Net Sales
520.30
406.10
28.12%
Operating Profit (PBDIT) excl Other Income
111.40
84.10
32.46%
Interest
8.20
6.40
28.12%
Exceptional Items
5.10
-2.50
304.00%
Consolidate Net Profit
63.30
23.30
171.67%
Operating Profit Margin (Excl OI)
130.20%
89.50%
4.07%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2023 is 28.12% vs 2.24% in Mar 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2023 is 171.67% vs -23.86% in Mar 2022

stock-summaryCompany CV
About JBM (Healthcare) Ltd. stock-summary
stock-summary
JBM (Healthcare) Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available